Actively Recruiting
COLON-MD: Colon Cancer Longitudinal Study
Led by Baylor Research Institute · Updated on 2026-01-26
11
Participants Needed
1
Research Sites
278 weeks
Total Duration
On this page
Sponsors
B
Baylor Research Institute
Lead Sponsor
B
Baylor University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this proposal is to identify how the composition of the gut microbiome and diet interact to impact chemotherapy-induced diarrhea incidence and severity.
CONDITIONS
Official Title
COLON-MD: Colon Cancer Longitudinal Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of colon cancer
- Age above 18 and up to 79 years
- Ability to give informed consent
- Expected to receive FOLFOX chemotherapy treatment
You will not qualify if you...
- Pregnant individuals
- Diagnosis of Lynch syndrome or familial adenomatous polyposis (FAP)
- Unable to give informed consent
- Unable to comply with follow-up program
- History of prior colon cancer diagnosis
- Antibiotic treatment within the last month
- Previous bowel resection surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Baylor Research Institute
Temple, Texas, United States, 76508
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here